Targacept narrows 3Q loss
13th Nov 2006, 22:53 GMT
Targacept posted a $4.9 mln loss in Q3, an improvement from the $6.9 mln it lost in the same quarter of 2005, according to an announcement.
Targacept narrows 3Q loss related news:
- Targacept narrows 3Q loss — Latest news from The Business Journal of the Greater Triad Area
- Solexa Narrows 3Q Loss — Bio-Technology News from StratCenter.com
- Muzak narrows 3Q loss, names CFO — Latest news from Charlotte Business Journal
- Taleo narrows Q3 loss — bizjournals.com Banking & Financial Services:Commercial Banking headlines
- Micrus narrows Q2 loss on 137% revenue jump — Latest news from Silicon Valley/San Jose Business Journal
- PokerTek posts 3Q loss of $2.3M — Latest news from Charlotte Business Journal
- Regency posts larger 3Q loss — Latest news from Dallas Business Journal
- Iomai 3Q Loss Widens — StratWire - Business of Healthcare NewsFeed
- Ford restates results for 5 years, narrows Q3 loss — Reuters: Business
- UGS Corp. posts wider 3Q loss — Latest news from Dallas Business Journal
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress